{"id":"https://openalex.org/W4403198155","doi":"https://doi.org/10.1111/bph.17357","title":"Inactivation induced by pathogenic Cav1.3 L\u2010type Ca2+\u2010channel variants enhances sensitivity for dihydropyridine Ca2+ channel blockers","display_name":"Inactivation induced by pathogenic Cav1.3 L\u2010type Ca2+\u2010channel variants enhances sensitivity for dihydropyridine Ca2+ channel blockers","publication_year":2024,"publication_date":"2024-10-07","ids":{"openalex":"https://openalex.org/W4403198155","doi":"https://doi.org/10.1111/bph.17357","pmid":"https://pubmed.ncbi.nlm.nih.gov/39370994"},"language":"en","primary_location":{"id":"doi:10.1111/bph.17357","doi":"https://doi.org/10.1111/bph.17357","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bph.17357","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.17357","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.17357","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000506463","display_name":"Ferenc T\u00f6r\u00f6k","orcid":"https://orcid.org/0009-0006-8133-5778","observed_orcids":["https://orcid.org/0009-0006-8133-5778"]},"institutions":[{"id":"https://openalex.org/I190249584","display_name":"Universit\u00e4t Innsbruck","ror":"https://ror.org/054pv6659","country_code":"AT","type":"education","lineage":["https://openalex.org/I190249584"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Ferenc T\u00f6r\u00f6k","raw_affiliation_strings":["Department of Pharmacology and Toxicology, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria","institution_ids":["https://openalex.org/I190249584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091807953","display_name":"Sarah Salamon","orcid":"https://orcid.org/0009-0005-7435-405X","observed_orcids":["https://orcid.org/0009-0005-7435-405X"]},"institutions":[{"id":"https://openalex.org/I180923762","display_name":"University of Cologne","ror":"https://ror.org/00rcxh774","country_code":"DE","type":"education","lineage":["https://openalex.org/I180923762"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Sarah Salamon","raw_affiliation_strings":["Center of Pharmacology, Institute II, University of Cologne, Cologne, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center of Pharmacology, Institute II, University of Cologne, Cologne, Germany","institution_ids":["https://openalex.org/I180923762"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042631052","display_name":"Nadine J. Ortner","orcid":"https://orcid.org/0000-0003-3882-3283","observed_orcids":["https://orcid.org/0000-0003-3882-3283"]},"institutions":[{"id":"https://openalex.org/I190249584","display_name":"Universit\u00e4t Innsbruck","ror":"https://ror.org/054pv6659","country_code":"AT","type":"education","lineage":["https://openalex.org/I190249584"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Nadine J. Ortner","raw_affiliation_strings":["Department of Pharmacology and Toxicology, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria","institution_ids":["https://openalex.org/I190249584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034034027","display_name":"Monica L. Fern\u00e1ndez\u2010Quintero","orcid":"https://orcid.org/0000-0002-6811-6283","observed_orcids":["https://orcid.org/0000-0002-6811-6283"]},"institutions":[{"id":"https://openalex.org/I190249584","display_name":"Universit\u00e4t Innsbruck","ror":"https://ror.org/054pv6659","country_code":"AT","type":"education","lineage":["https://openalex.org/I190249584"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Monica L. Fern\u00e1ndez\u2010Quintero","raw_affiliation_strings":["Department of General, Inorganic and Theoretical Chemistry, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of General, Inorganic and Theoretical Chemistry, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria","institution_ids":["https://openalex.org/I190249584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007578013","display_name":"Jan Matthes","orcid":"https://orcid.org/0000-0003-2754-1555","observed_orcids":["https://orcid.org/0000-0003-2754-1555"]},"institutions":[{"id":"https://openalex.org/I180923762","display_name":"University of Cologne","ror":"https://ror.org/00rcxh774","country_code":"DE","type":"education","lineage":["https://openalex.org/I180923762"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Jan Matthes","raw_affiliation_strings":["Center of Pharmacology, Institute II, University of Cologne, Cologne, Germany"],"raw_orcid":"https://orcid.org/0000-0003-2754-1555","affiliations":[{"raw_affiliation_string":"Center of Pharmacology, Institute II, University of Cologne, Cologne, Germany","institution_ids":["https://openalex.org/I180923762"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064224098","display_name":"J\u00f6rg Striessnig","orcid":"https://orcid.org/0000-0002-9406-7120","observed_orcids":["https://orcid.org/0000-0002-9406-7120"]},"institutions":[{"id":"https://openalex.org/I190249584","display_name":"Universit\u00e4t Innsbruck","ror":"https://ror.org/054pv6659","country_code":"AT","type":"education","lineage":["https://openalex.org/I190249584"]}],"countries":["AT"],"is_corresponding":true,"raw_author_name":"J\u00f6rg Striessnig","raw_affiliation_strings":["Department of Pharmacology and Toxicology, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria"],"raw_orcid":"https://orcid.org/0000-0002-9406-7120","affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria","institution_ids":["https://openalex.org/I190249584"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5064224098"],"corresponding_institution_ids":["https://openalex.org/I190249584"],"apc_list":{"value":4550,"currency":"USD","value_usd":4550},"apc_paid":{"value":4550,"currency":"USD","value_usd":4550},"fwci":0.3336,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":{"value":0.44044813,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"182","issue":"1","first_page":"181","last_page":"197"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10493","display_name":"Ion channel regulation and function","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10493","display_name":"Ion channel regulation and function","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11642","display_name":"Genomics and Rare Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cav1-3-l-type-calcium-channels","display_name":"Cav1.3 L-type calcium channel","score":0.9150000214576721},{"id":"https://openalex.org/keywords/cacna1d","display_name":"CACNA1D","score":0.9679999947547913},{"id":"https://openalex.org/keywords/gain-of-function-mutations","display_name":"gain-of-function mutations","score":0.8880000114440918},{"id":"https://openalex.org/keywords/isradipine","display_name":"isradipine","score":0.949999988079071},{"id":"https://openalex.org/keywords/dihydropyridine-calcium-channel-blockers","display_name":"dihydropyridine calcium channel blockers","score":0.9639999866485596},{"id":"https://openalex.org/keywords/channel-inactivation","display_name":"channel inactivation","score":0.8989999890327454},{"id":"https://openalex.org/keywords/voltage-dependent-inactivation","display_name":"voltage-dependent inactivation","score":0.746999979019165},{"id":"https://openalex.org/keywords/voltage-dependent-activation","display_name":"voltage dependence of activation","score":0.7429999709129333},{"id":"https://openalex.org/keywords/channel-gating","display_name":"channel gating","score":0.6269999742507935},{"id":"https://openalex.org/keywords/neurodevelopmental-disorders","display_name":"neurodevelopmental disorders","score":0.8579999804496765},{"id":"https://openalex.org/keywords/endocrine-disorders","display_name":"endocrine disorders","score":0.5879999995231628},{"id":"https://openalex.org/keywords/de-novo-missense-variant","display_name":"de novo missense variant","score":0.7839999794960022},{"id":"https://openalex.org/keywords/molecular-dynamics-simulation","display_name":"molecular dynamics simulation","score":0.7260000109672546}],"concepts":[{"id":"https://openalex.org/C2776066529","wikidata":"https://www.wikidata.org/wiki/Q414873","display_name":"Isradipine","level":4,"score":0.8956873416900635},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6594674587249756},{"id":"https://openalex.org/C207583985","wikidata":"https://www.wikidata.org/wiki/Q128723","display_name":"Wild type","level":4,"score":0.6301193833351135},{"id":"https://openalex.org/C194544171","wikidata":"https://www.wikidata.org/wiki/Q21105679","display_name":"Gating","level":2,"score":0.6246667504310608},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.5595062971115112},{"id":"https://openalex.org/C2781212610","wikidata":"https://www.wikidata.org/wiki/Q39094","display_name":"Dihydropyridine","level":3,"score":0.5591748356819153},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.5449695587158203},{"id":"https://openalex.org/C147944092","wikidata":"https://www.wikidata.org/wiki/Q176366","display_name":"Patch clamp","level":3,"score":0.44764232635498047},{"id":"https://openalex.org/C18699975","wikidata":"https://www.wikidata.org/wiki/Q14905735","display_name":"Voltage-dependent calcium channel","level":3,"score":0.4178091287612915},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.24996435642242432},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23132702708244324},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.21655502915382385},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.15963175892829895},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D004095","descriptor_name":"Dihydropyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004095","descriptor_name":"Dihydropyridines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017275","descriptor_name":"Isradipine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D020125","descriptor_name":"Mutation, Missense","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020746","descriptor_name":"Calcium Channels, L-Type","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D020746","descriptor_name":"Calcium Channels, L-Type","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D020746","descriptor_name":"Calcium Channels, L-Type","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D056004","descriptor_name":"Molecular Dynamics Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/bph.17357","doi":"https://doi.org/10.1111/bph.17357","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bph.17357","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.17357","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:39370994","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39370994","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:ulb-dok.uibk.ac.at/:12787500","doi":null,"is_oa":true,"landing_page_url":"https://ulb-dok.uibk.ac.at/doi/10.1111/bph.17357","pdf_url":"https://ulb-dok.uibk.ac.at/ulbtirolfodok/content/titleinfo/12787500/full.pdf","source":{"id":"https://openalex.org/S4306401999","display_name":"Digital Library of the University of Innsbruck (University of Innsbruck)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I143397708","host_organization_name":"Innsbruck Medical University","host_organization_lineage":["https://openalex.org/I143397708"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1111/bph.17357","doi":"https://doi.org/10.1111/bph.17357","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bph.17357","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.17357","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1397978827","display_name":"CavX - Calcium channels in excitable cells","funder_award_id":"DOC 30","funder_id":"https://openalex.org/F4320321181","funder_display_name":"Austrian Science Fund"},{"id":"https://openalex.org/G3055761856","display_name":null,"funder_award_id":"847681","funder_id":"https://openalex.org/F4320321181","funder_display_name":"Austrian Science Fund"},{"id":"https://openalex.org/G4176180851","display_name":"Ageing, Regeneration, and Drug Research","funder_award_id":"847681","funder_id":"https://openalex.org/F4320338337","funder_display_name":"H2020 Marie Sk\u0142odowska-Curie Actions"},{"id":"https://openalex.org/G4495373907","display_name":null,"funder_award_id":"DOI 10.55776","funder_id":"https://openalex.org/F4320321181","funder_display_name":"Austrian Science Fund"},{"id":"https://openalex.org/G4680220858","display_name":null,"funder_award_id":"DOI 10.55776/DOC30","funder_id":"https://openalex.org/F4320321181","funder_display_name":"Austrian Science Fund"},{"id":"https://openalex.org/G5526615305","display_name":null,"funder_award_id":"DOI 10.55776/P35087","funder_id":"https://openalex.org/F4320321181","funder_display_name":"Austrian Science Fund"},{"id":"https://openalex.org/G6897683985","display_name":"Cav1.3-selective L-type calcium channel blockers","funder_award_id":"P 35722","funder_id":"https://openalex.org/F4320321181","funder_display_name":"Austrian Science Fund"},{"id":"https://openalex.org/G6919689813","display_name":"Dopamine system in a neurodevelopmental disorder mouse model","funder_award_id":"P 35087","funder_id":"https://openalex.org/F4320321181","funder_display_name":"Austrian Science Fund"},{"id":"https://openalex.org/G8339780616","display_name":null,"funder_award_id":"DOI 10.55776/P35722","funder_id":"https://openalex.org/F4320321181","funder_display_name":"Austrian Science Fund"},{"id":"https://openalex.org/G8590477180","display_name":null,"funder_award_id":"10.55776","funder_id":"https://openalex.org/F4320321181","funder_display_name":"Austrian Science Fund"}],"funders":[{"id":"https://openalex.org/F4320321181","display_name":"Austrian Science Fund","ror":"https://ror.org/013tf3c58"},{"id":"https://openalex.org/F4320338337","display_name":"H2020 Marie Sk\u0142odowska-Curie Actions","ror":null}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4403198155.pdf","grobid_xml":"https://content.openalex.org/works/W4403198155.grobid-xml"},"referenced_works_count":54,"referenced_works":["https://openalex.org/W1031578623","https://openalex.org/W1921440755","https://openalex.org/W1967440935","https://openalex.org/W1976499671","https://openalex.org/W1983803713","https://openalex.org/W1987327282","https://openalex.org/W1989415425","https://openalex.org/W1996309216","https://openalex.org/W2002474522","https://openalex.org/W2018931883","https://openalex.org/W2029706895","https://openalex.org/W2051978340","https://openalex.org/W2065008766","https://openalex.org/W2067174909","https://openalex.org/W2077936658","https://openalex.org/W2081693079","https://openalex.org/W2084650733","https://openalex.org/W2087484885","https://openalex.org/W2095836715","https://openalex.org/W2112161053","https://openalex.org/W2115791394","https://openalex.org/W2128572087","https://openalex.org/W2140831051","https://openalex.org/W2150008646","https://openalex.org/W2155735267","https://openalex.org/W2165126772","https://openalex.org/W2168269595","https://openalex.org/W2206954826","https://openalex.org/W2464996892","https://openalex.org/W2529826539","https://openalex.org/W2555870966","https://openalex.org/W2611121922","https://openalex.org/W2623805123","https://openalex.org/W2792530460","https://openalex.org/W2900901504","https://openalex.org/W2996168650","https://openalex.org/W3003323971","https://openalex.org/W3005633291","https://openalex.org/W3016804489","https://openalex.org/W3020160330","https://openalex.org/W3037305971","https://openalex.org/W3124616979","https://openalex.org/W4206359742","https://openalex.org/W4282941439","https://openalex.org/W4303647625","https://openalex.org/W4319661234","https://openalex.org/W4320714796","https://openalex.org/W4328048772","https://openalex.org/W4386691303","https://openalex.org/W4386691497","https://openalex.org/W4386877662","https://openalex.org/W4390025012","https://openalex.org/W4390025027","https://openalex.org/W4393574526"],"related_works":["https://openalex.org/W4386886019","https://openalex.org/W2228398811","https://openalex.org/W4211038175","https://openalex.org/W2793047063","https://openalex.org/W3003323971","https://openalex.org/W4303647625","https://openalex.org/W4386691303","https://openalex.org/W2900901504","https://openalex.org/W1420849759","https://openalex.org/W2611121922"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"and":[2,37,39,62,70,76,111,129,154,177,186,190],"Purpose":[3],"Pathogenic":[4],"gain\u2010of\u2010function":[5],"mutations":[6,35,118,141],"in":[7,67,102,108,240],"Cav1.3":[8,238],"L\u2010type":[9],"voltage\u2010gated":[10],"Ca2+\u2010channels":[11],"(CACNA1D)":[12],"cause":[13],"neurodevelopmental":[14],"disorders":[15],"with":[16,158],"or":[17],"without":[18,246],"endocrine":[19],"symptoms.":[20],"We":[21],"aimed":[22],"to":[23,123,148,169,224],"confirm":[24],"a":[25,53,212],"pathogenic":[26,121,193],"gain\u2010of":[27],"function":[28],"phenotype":[29],"of":[30,82,92,126,181,219],"CACNA1D":[31],"de":[32],"novo":[33],"missense":[34],"A749T":[36,189],"L271H,":[38],"investigated":[40,106],"the":[41,49,103,164,217],"molecular":[42,96,112],"mechanism":[43],"causing":[44],"their":[45,71,206,225],"enhanced":[46],"sensitivity":[47,146,210],"for":[48,56,98,152,175,248],"Ca2+\u2010channel":[50],"blocker":[51],"isradipine,":[52],"potential":[54],"therapeutic":[55],"affected":[57],"patients.":[58],"Experimental":[59],"Approach":[60],"Wildtype":[61],"mutant":[63,155,249],"channels":[64,156,182,222,239],"were":[65,119,183],"expressed":[66],"tsA\u2010201":[68],"cells":[69],"gating":[72,101,194],"analysed":[73],"using":[74,87,107],"whole\u2010cell":[75],"single\u2010channel":[77],"patch\u2010clamp":[78],"recordings.":[79],"The":[80,95,150,171],"voltage\u2010dependence":[81],"isradipine":[83,145,198,233],"action":[84],"was":[85,105,173],"quantified":[86],"protocols":[88],"inducing":[89],"variable":[90],"fractions":[91],"inactivated":[93,221],"channels.":[94,250],"basis":[97],"altered":[99],"channel":[100,159],"mutants":[104,178],"silico":[109],"modelling":[110],"dynamics":[113],"simulations.":[114],"Key":[115],"Results":[116],"Both":[117],"confirmed":[120],"due":[122,223],"characteristic":[124],"shifts":[125],"voltage\u2010dependent":[127],"activation":[128],"inactivation":[130,160,228],"towards":[131],"negative":[132,137,214,227],"potentials":[133,139],"(~20":[134],"mV).":[135],"At":[136],"holding":[138],"both":[140],"showed":[142],"significantly":[143],"higher":[144,208],"compared":[147],"wildtype.":[149],"affinity":[151],"wildtype":[153,176],"increased":[157],"as":[161],"predicted":[162],"by":[163,216],"modulated":[165],"receptor":[166],"hypothesis":[167],"(30\u2010":[168],"40\u2010fold).":[170],"IC50":[172],"indistinguishable":[174],"when":[179],">50%":[180],"inactivated.":[184],"Conclusions":[185],"Implications":[187],"Mutations":[188],"L271H":[191],"induce":[192],"changes.":[195],"Like":[196],"wildtype,":[197],"inhibition":[199],"is":[200],"strongly":[201],"voltage\u2010dependent.":[202],"Our":[203],"data":[204],"explains":[205],"apparent":[207],"drug":[209],"at":[211],"given":[213],"voltage":[215,229],"availability":[218],"more":[220,226],"range.":[230],"Low":[231],"nanomolar":[232],"concentrations":[234],"will":[235],"only":[236],"inhibit":[237],"neurons":[241],"during":[242],"prolonged":[243],"depolarized":[244],"states":[245],"selectivity":[247]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2024-10-08T00:00:00"}